#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sarcoma Breast angiosarcoma metastatic Non-small cell lung cancer metastatic Macular telangiectasia Bladder cancer Glomerulonephritis acute Renal disorder Pyoderma gangrenosum Hyperchylomicronaemia Congenital megacolon Hypocalcaemia Squamous cell carcinoma of the vulva Fragile X syndrome Primary amyloidosis Squamous cell carcinoma of the hypopharynx More trials…

    Learn about Rare Diseases

    IgA nephropathy – Trials in Disease Hairy cell leukaemia recurrent – Life with Disease Biotinidase deficiency – Life with Disease Atypical haemolytic uraemic syndrome – Life with Disease Niemann-Pick disease Rhabdomyosarcoma – Treatment Kearns-Sayre syndrome Prader-Willi syndrome Haemophilia – Diagnostics Paroxysmal nocturnal haemoglobinuria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Octreotide Hydrochloride Rly-4008 Citalopram Benzocaine [99MTC]PSMA I&S Acetazolamide Carbidopa Op-1250 Sebetralstat Sibeprenlimab Calcium Polystyrene Sulfonate Amylase Imipramine Hydrochloride Anhydrous Benzoyl Peroxide Tamoxifen Citrate 177LU-PSMA-I&T Belzupacap Sarotalocan Alxn1850 Biotin Atomoxetine More therapies…

    Learn about Your Condition

    Non-Hodgkin's lymphoma Thrombosis prophylaxis Restless legs syndrome HIV infection Urethral stenosis Transient ischaemic attack Procedural anxiety Reperfusion injury Lung cancer metastatic Usher's syndrome Chronic hepatitis C Deafness bilateral Hodgkin's disease Follicular lymphoma stage II Lymphangioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Kliiniliste Uuringute Keskus OÜ

Kliiniliste Uuringute Keskus OÜ

Sobra Tn 54/1, Tartu, 50106, Estonia

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Sodium Chloride
    Belgium Estonia Finland France Germany Italy +1

  • Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Belgium Czechia Denmark Estonia Finland Germany +5

  • Study on the Safety and Immune Response of a High-Dose Influenza Vaccine in Adults Aged 60 and Over, Comparing Trivalent Influenza Vaccine with a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238)
    • Influenza A Virus/Thailand/8/2022 (H3N2)-Like Strain (A/California/122/2022, San-022), Inactivated
    • Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated
    Belgium Bulgaria Estonia Finland Spain

  • Study on the Safety and Immune Response of a 21-Valent Pneumococcal Vaccine in Healthy Infants, Toddlers, Children, and Adolescents

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 1
    • Pneumococcal Polysaccharide Serotype 10A
    • Pneumococcal Polysaccharide Serotype 11A
    Estonia Poland

  • Study on the Safety and Immune Response of aQIVc HD Vaccine Compared to a Drug Combination for Adults 50 Years and Older at Risk of Flu Complications

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • A/(H3N2)-LIKE VIRUS ANTIGEN
    • A/DARWIN/9/2021 (H3N2) – LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
    • A/H1N1 INFLUENZA VACCINE
    Denmark Estonia Germany

  • Study of HSV immunotherapy (HSVTI) for healthy adults aged 18-40 and people with recurrent genital herpes aged 18-60

    Not recruiting

    2 1
    Investigated Diseases:
    • Herpes simplex
    Investigated Drugs:
    • GSKVX000000030810
    • GSKVX000000030825
    • GSKVX000000030918
    Belgium Estonia Germany Spain

  • Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 1
    • Pneumococcal Polysaccharide Serotype 10A
    • Pneumococcal Polysaccharide Serotype 11A
    Belgium Czechia Estonia Finland Germany Greece +3

  • Study on Long-Term Effects and Safety of Herpes Zoster Vaccine with Recombinant Varicella Zoster Virus Glycoprotein E in Older Adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Herpes zoster
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Czechia Estonia Finland France Germany Italy +2

  • Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1
    Investigated Drugs:
    • Envudeucitinib
    Austria Belgium Bulgaria Czechia Estonia France +7
Previous Page
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!